Skip to main content

Table 2 treatment and response of HBs associated to prognoses

From: Analysis of factors related to recurrence of paediatric hepatoblastoma - a single Centre retrospective study

Variables Results3-year RFS rateP
AFP decreased after neoadjuvant chemotherapy (n, %)   0.005
 <  60%26 (46)28% 
 ≥ 60%30 (54)68% 
Evaluation criteria of WHO (n, %)   0.004
 CR0  
 PR32 (57)65.6% 
 SD24 (43)29.2% 
 PD0  
POSTTEXT (n, %)   0.476
 I9 (16)66.7% 
 II30 (54)50.0% 
 III17 (30)41.1% 
 IV0  
Surgical strategy (n, %)   0.747
 Left lobectomy14 (25)42.9% 
 Right lobectomy33 (59)54.6% 
 Extended hepatectomy9 (16)44.4% 
AFP fell to normal (n, %)   0.0005
 <  6 months27 (48)68.6% 
 ≥ 6 months29 (52)50.0% 
  1. POSTTEXT”- Posttreatment extension stage; “CR”- complete response; “PR”- partial response; “SD”- stable disease; “PD”- progressive disease